FDA user fee agreements: advancing medical product regulation and innovation for the benefit of patients, FDA center directors : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Seventeenth Congress, second session on examining Food and Drug Administration user fee agreements, focusing on advancing medical product regulation and innovation for the benefit of patients and Food and Drug Administration center directors, April 26, 2022.